%0 Generic
%A Lewis, Karl
%A Ascierto, Paolo
%A Robert, Caroline
%A Munhoz, Rodrigo
%A Liszkay, Gabriella
%A De La Cruz Marino, Luis
%A Olah, Judit
%A Queirolo, Paola
%A Mackiewicz, Jacek
%A Shah, Kalpit
%A Forbes, Harper
%A Hertig, Christian
%A Yan, Yibing
%A Gutzmer, Ralf
%A McArthur, Grant
%T ATEZOLIZUMAB PLUS VEMURAFENIB AND COBIMETINIB PROVIDES FAVORABLE SURVIVAL OUTCOMES IN PATIENTS WITH HIGH TUMOR MUTATION BURDEN AND PROINFLAMMATORY GENE SIGNATURE IN THE PHASE 3 IMSPIRE150 STUDY
%D 2020
%U https://hdl.handle.net/10668/27584
%~